Triple negative breast cancer (TNBC) is characterized by lack of expression of estrogen (ER) and progesterone (PR) receptors and lack of overexpression of the human epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to triple-negative breast carcinoma.